Trial intelligence / Profile preview

AUY922, BYL719, INC280, LDK378, MEK162 monotherapy in advanced NSCLC with molecular abnormalities

CTR20140725Phase 2Completed

Sponsor

Novartis

Start

Dec 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1